---
nav_exclude: true
title: 'å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W08'
layout: default
datePublished: '2026-02-18T12:00:00+08:00'
dateModified: '2026-02-19T14:00:00+08:00'
seo:
  meta:
    title: 'å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W08 | EpiAlert ç–«æƒ…å¿«è¨Š'
    description: 'æœ¬é€±é‡é»ï¼šUKHSA é¦–ä»½å¯’å†·æ­»äº¡ç‡å ±å‘Šã€ECDC æŠ—è—¥æ€§è­¦å‘Šã€RSV ç–«è‹—ç¯„æœ¬ã€HCID é¢¨éšªæ¸…å–®æ›´æ–°ã€‚'
    og:title: 'å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W08 | EpiAlert'
    og:description: 'UKHSA ç™¼å¸ƒé¦–ä»½å¯’å†·æ­»äº¡ç‡å ±å‘Šï¼ˆ2,544 ä¾‹æ­»äº¡ï¼‰ã€ECDC/EFSA æŠ—ç”Ÿç´ æŠ—è—¥æ€§è­¦å‘Šã€RSV ç–«è‹— PGD ç¯„æœ¬ç™¼å¸ƒã€HCID é¢¨éšªæ¸…å–®æ›´æ–°ã€‚'
    og:type: 'article'
    og:url: 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W08-weekly-digest'
    og:image: 'https://epialert.weiqi.kids/assets/images/logo.png'
    article:published_time: '2026-02-18T12:00:00+08:00'
    article:modified_time: '2026-02-19T14:00:00+08:00'
    twitter:card: 'summary_large_image'
  json_ld:
    '@context': 'https://schema.org'
    '@graph':
      - '@type': 'WebPage'
        '@id': 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W08-weekly-digest#webpage'
        url: 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W08-weekly-digest'
        name: 'å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W08'
        description: 'é¦–ä»½å¯’å†·æ­»äº¡ç‡å ±å‘Šã€é£Ÿæºæ€§ç´°èŒæŠ—è—¥æ€§ã€RSV ç–«è‹— PGD ç¯„æœ¬ã€HCID é¢¨éšªæ¸…å–®æ›´æ–°'
        inLanguage: 'zh-TW'
        isPartOf:
          '@id': 'https://epialert.weiqi.kids#website'
        primaryImageOfPage:
          '@type': 'ImageObject'
          url: 'https://epialert.weiqi.kids/assets/images/logo.png'
        datePublished: '2026-02-18T12:00:00+08:00'
        dateModified: '2026-02-19T14:00:00+08:00'
        speakable:
          '@type': 'SpeakableSpecification'
          cssSelector:
            - '.article-summary'
            - '.speakable-content'
            - '.key-takeaway'
            - '.key-answer'
            - '.expert-quote'
            - '.actionable-steps li'
            - '.faq-answer-content'
      - '@type': 'Article'
        '@id': 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W08-weekly-digest#article'
        mainEntityOfPage:
          '@id': 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W08-weekly-digest#webpage'
        significantLink:
          - 'https://epialert.weiqi.kids/Extractor/uk_ukhsa_updates/'
          - 'https://epialert.weiqi.kids/Extractor/ecdc_cdtr/'
          - 'https://epialert.weiqi.kids/Extractor/tw_cdc_alerts/'
        headline: 'å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W08'
        alternativeHeadline: 'Infectious Disease Threats Weekly Report 2026-W08'
        description: 'æœ¬é€±é‡é»ï¼šUKHSA ç™¼å¸ƒé¦–ä»½å¯’å†·æ­»äº¡ç‡å ±å‘Šã€ECDC/EFSA æŠ—ç”Ÿç´ æŠ—è—¥æ€§è­¦å‘Šã€RSV ç–«è‹— PGD ç¯„æœ¬ã€HCID é¢¨éšªæ¸…å–®æ›´æ–°'
        image:
          '@type': 'ImageObject'
          url: 'https://epialert.weiqi.kids/assets/images/logo.png'
          width: 1200
          height: 630
        author:
          '@id': 'https://epialert.weiqi.kids/about#person'
        publisher:
          '@id': 'https://epialert.weiqi.kids#organization'
        datePublished: '2026-02-18T12:00:00+08:00'
        dateModified: '2026-02-19T14:00:00+08:00'
        articleSection: 'é€±å ±'
        keywords: 'RSV, å‘¼å¸é“èåˆç—…æ¯’, ç–«è‹—, éº»ç–¹, ç™¾æ—¥å’³, çŒ´ç—˜, Mpox, ç¦½æµæ„Ÿ, H5N1, æŠ—ç”Ÿç´ æŠ—è—¥æ€§, AMR, å¯’å†·æ­»äº¡ç‡, HCID, å‚³æŸ“ç—…ç›£æ¸¬, ç–«æƒ…é€±å ±'
        wordCount: 7500
        inLanguage: 'zh-TW'
        isAccessibleForFree: true
        isPartOf:
          '@type': 'WebSite'
          '@id': 'https://epialert.weiqi.kids#website'
          name: 'EpiAlert ç–«æƒ…å¿«è¨Š'
          potentialAction:
            '@type': 'SearchAction'
            target: 'https://epialert.weiqi.kids/search?q={search_term}'
            query-input: 'required name=search_term'
      - '@type': 'Person'
        '@id': 'https://epialert.weiqi.kids/about#person'
        name: 'EpiAlert AI ç·¨è¼¯'
        url: 'https://epialert.weiqi.kids/about'
        description: 'AI é©…å‹•çš„ç–«æƒ…è³‡è¨Šå½™æ•´ç³»çµ±ï¼Œè‡ªå‹•æ”¶é›†ä¸¦åˆ†æä¾†è‡ª WHOã€CDC ç­‰å®˜æ–¹ä¾†æºçš„å‚³æŸ“ç—…æƒ…å ±'
        worksFor:
          '@id': 'https://epialert.weiqi.kids#organization'
        knowsAbout:
          - 'å‚³æŸ“ç—…ç›£æ¸¬'
          - 'å…¬å…±è¡›ç”Ÿ'
          - 'ç–«æƒ…åˆ†æ'
          - 'æµè¡Œç—…å­¸'
        hasCredential:
          - '@type': 'EducationalOccupationalCredential'
            name: 'AI è¼”åŠ©é†«ç™‚è³‡è¨Šç³»çµ±'
            credentialCategory: 'Automated Health Intelligence System'
        sameAs:
          - 'https://github.com/anthropics/claude-code'
      - '@type': 'Organization'
        '@id': 'https://epialert.weiqi.kids#organization'
        name: 'EpiAlert ç–«æƒ…å¿«è¨Š'
        url: 'https://epialert.weiqi.kids'
        logo:
          '@type': 'ImageObject'
          url: 'https://epialert.weiqi.kids/assets/images/logo.png'
          width: 600
          height: 60
        description: 'å…¨çƒå‚³æŸ“ç—…æƒ…å ±è‡ªå‹•æ”¶é›†èˆ‡åˆ†æç³»çµ±'
        sameAs:
          - 'https://github.com/anthropics/claude-code'
        contactPoint:
          '@type': 'ContactPoint'
          contactType: 'technical support'
          url: 'https://github.com/anthropics/claude-code/issues'
      - '@type': 'BreadcrumbList'
        itemListElement:
          - '@type': 'ListItem'
            position: 1
            name: 'é¦–é '
            item: 'https://epialert.weiqi.kids'
          - '@type': 'ListItem'
            position: 2
            name: 'é€±å ±'
            item: 'https://epialert.weiqi.kids/Narrator/weekly_digest/'
          - '@type': 'ListItem'
            position: 3
            name: 'å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W08'
            item: 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W08-weekly-digest'
      - '@type': 'ItemList'
        '@id': 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W08-weekly-digest#highlights'
        name: 'æœ¬é€±å‚³æŸ“ç—…å¨è„…é‡é»'
        description: '2026 å¹´ç¬¬ 8 é€±å…¨çƒå‚³æŸ“ç—…å¨è„…æ‘˜è¦'
        numberOfItems: 6
        itemListElement:
          - '@type': 'ListItem'
            position: 1
            name: 'UKHSA ç™¼å¸ƒé¦–ä»½å¯’å†·æ­»äº¡ç‡å ±å‘Š'
            description: '2024-25 å¹´å†¬å­£è‹±æ ¼è˜­ 2,544 ä¾‹æ­»äº¡èˆ‡å¯’å†·å¤©æ°£ç›¸é—œï¼Œ65 æ­²ä»¥ä¸ŠåŠå¿ƒè¡€ç®¡ç–¾ç—…æ‚£è€…é¢¨éšªæœ€é«˜'
          - '@type': 'ListItem'
            position: 2
            name: 'ECDC/EFSA é£Ÿæºæ€§ç´°èŒæŠ—è—¥æ€§è­¦å‘Š'
            description: 'æ²™é–€æ°èŒå’Œå½æ›²æ¡¿èŒç’°ä¸™æ²™æ˜ŸæŠ—è—¥æ€§æŒçºŒé«˜ä¼ï¼Œç¢³é’é»´çƒ¯é…¶ç”¢ç”Ÿå‹å¤§è…¸æ¡¿èŒæª¢å‡ºç‡ä¸Šå‡'
          - '@type': 'ListItem'
            position: 3
            name: 'è‹±åœ‹ç™¼å¸ƒ RSV ç–«è‹— PGD ç¯„æœ¬'
            description: 'UKHSA ç™¼å¸ƒå‘¼å¸é“èåˆç—…æ¯’ç–«è‹—çš„æ‚£è€…ç¾¤çµ„æŒ‡ç¤ºç¯„æœ¬ï¼Œæ”¯æ´å­•å©¦åŠ 75 æ­²ä»¥ä¸Šé•·è€…çš„åœ‹å®¶ç–«è‹—æ¥ç¨®è¨ˆç•«'
          - '@type': 'ListItem'
            position: 4
            name: 'HCID é¢¨éšªæ¸…å–®æ›´æ–°'
            description: 'UKHSA æ›´æ–°é«˜å¾Œæœå‚³æŸ“ç—…åœ‹å®¶é¢¨éšªæ¸…å–®ï¼Œå°åº¦è¥¿å­ŸåŠ æ‹‰é‚¦å°¼å¸•ç—…æ¯’ç–«æƒ…åˆ—å…¥è¿½è¹¤'
          - '@type': 'ListItem'
            position: 5
            name: 'éº»ç–¹ã€ç™¾æ—¥å’³æŒçºŒè¿½è¹¤'
            description: 'å°ç£ä»Šå¹´é¦–ä¾‹éº»ç–¹åŠç™¾æ—¥å’³ç—…ä¾‹é€²å…¥æ¥è§¸è€…ç›£æ¸¬æœŸï¼Œå…¨çƒç–«æƒ…ä»ç„¶åš´å³»'
          - '@type': 'ListItem'
            position: 6
            name: 'çŒ´ç—˜ Mpox ç›£æ¸¬æŒçºŒ'
            description: 'UKHSA æŒçºŒæ›´æ–° clade Ib åŠ clade IIb æµè¡Œç—…å­¸æ¦‚æ³ï¼Œè‹±åœ‹ç¶­æŒç›£æ¸¬'
      - '@type': 'Table'
        '@id': 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W08-weekly-digest#comparison'
        about: 'èˆ‡ä¸Šé€±ç–«æƒ…æ¯”è¼ƒ'
        description: 'æ–°å¢å¨è„…ã€å‡ç´šè­¦ç¤ºã€æŒçºŒé—œæ³¨ã€å·²è§£é™¤é …ç›®çš„å®Œæ•´æ¯”è¼ƒ'
  ymyl:
    lastReviewed: '2026-02-19T14:00:00+08:00'
    reviewedBy: 'EpiAlert AI ç·¨è¼¯'
    medicalDisclaimer: 'æœ¬å ±å‘Šç”±è‡ªå‹•åŒ–ç³»çµ±ç”Ÿæˆï¼Œåƒ…ä¾›åƒè€ƒç”¨é€”ã€‚å ±å‘Šå…§å®¹åŸºæ–¼å…¬é–‹è³‡è¨Šä¾†æºï¼Œä¸æ§‹æˆé†«ç™‚å»ºè­°ã€å®˜æ–¹æ”¿ç­–æˆ–å°ˆæ¥­è¨ºæ–·ã€‚ä½¿ç”¨è€…æ‡‰è‡ªè¡Œé©—è­‰è³‡è¨Šä¸¦è«®è©¢å°ˆæ¥­äººå£«ã€‚'
---

# å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W08

<div class="ymyl-disclaimer">
æœ¬ç«™å…§å®¹ç”± AI è‡ªå‹•å½™æ•´è‡ª WHOã€CDC ç­‰å®˜æ–¹ä¾†æºï¼Œåƒ…ä¾›åƒè€ƒï¼Œä¸æ§‹æˆé†«ç™‚å»ºè­°ã€‚å¦‚æœ‰å¥åº·ç–‘æ…®ï¼Œè«‹è«®è©¢å°ˆæ¥­é†«ç™‚äººå“¡ã€‚
</div>

> **å…è²¬è²æ˜**
>
> æœ¬å ±å‘Šç”±è‡ªå‹•åŒ–ç³»çµ±ç”Ÿæˆï¼Œåƒ…ä¾›åƒè€ƒç”¨é€”ã€‚å ±å‘Šå…§å®¹åŸºæ–¼å…¬é–‹è³‡è¨Šä¾†æºï¼Œ
> ä¸æ§‹æˆé†«ç™‚å»ºè­°ã€å®˜æ–¹æ”¿ç­–æˆ–å°ˆæ¥­è¨ºæ–·ã€‚ä½¿ç”¨è€…æ‡‰è‡ªè¡Œé©—è­‰è³‡è¨Šä¸¦è«®è©¢
> å°ˆæ¥­äººå£«ã€‚

---

## æœ¬é€±é‡é»
{: .speakable-content}

<div class="key-takeaway" markdown="1">

- **UKHSA ç™¼å¸ƒé¦–ä»½å¯’å†·æ­»äº¡ç‡å ±å‘Š**ï¼š2024-25 å¹´å†¬å­£è‹±æ ¼è˜­ 2,544 ä¾‹æ­»äº¡èˆ‡å¯’å†·å¤©æ°£ç›¸é—œï¼Œä¸»è¦é€éå¿ƒè‡Ÿç—…ç™¼ä½œã€ä¸­é¢¨å’Œå‘¼å¸é“å•é¡Œç­‰é–“æ¥é€”å¾‘å½±éŸ¿ï¼Œ65 æ­²ä»¥ä¸Šé•·è€…åŠå¿ƒè¡€ç®¡ç–¾ç—…æ‚£è€…é¢¨éšªæœ€é«˜ã€‚(uk_ukhsa_updates) **[æœ¬é€±æ–°å¢]**

- **ECDC/EFSA ç™¼å¸ƒé£Ÿæºæ€§ç´°èŒæŠ—è—¥æ€§è­¦å‘Š**ï¼šæ²™é–€æ°èŒå’Œå½æ›²æ¡¿èŒå°ç’°ä¸™æ²™æ˜Ÿï¼ˆCiprofloxacinï¼‰æŠ—è—¥æ€§æŒçºŒé«˜ä¼ï¼Œç¢³é’é»´çƒ¯é…¶ç”¢ç”Ÿå‹å¤§è…¸æ¡¿èŒåœ¨é£Ÿç”¨å‹•ç‰©åŠè‚‰å“ä¸­çš„æª¢å‡ºç‡ä¸Šå‡ï¼Œå¼·èª¿ One Health ç­–ç•¥çš„é‡è¦æ€§ã€‚(ecdc_cdtr) **[æœ¬é€±æ–°å¢]**

- **è‹±åœ‹ç™¼å¸ƒ RSV ç–«è‹— PGD ç¯„æœ¬**ï¼šUKHSA ç™¼å¸ƒå‘¼å¸é“èåˆç—…æ¯’ï¼ˆRSVï¼‰ç–«è‹—çš„æ‚£è€…ç¾¤çµ„æŒ‡ç¤ºï¼ˆPGDï¼‰ç¯„æœ¬ï¼Œæ”¯æ´å­•å©¦ä¿è­·å¬°å…’åŠ 75 æ­²ä»¥ä¸Šé•·è€…çš„åœ‹å®¶ç–«è‹—æ¥ç¨®è¨ˆç•«ã€‚(uk_ukhsa_updates)

- **HCID é¢¨éšªæ¸…å–®æ›´æ–°**ï¼šUKHSA æ›´æ–°å…¨çƒé«˜å¾Œæœå‚³æŸ“ç—…ï¼ˆHCIDï¼‰åœ‹å®¶é¢¨éšªæ¸…å–®ï¼Œå°åº¦è¥¿å­ŸåŠ æ‹‰é‚¦æ–¼ 2026 å¹´ 1 æœˆ 13 æ—¥ç¢ºèªçˆ†ç™¼å°¼å¸•ç—…æ¯’ç–«æƒ…ã€‚(uk_ukhsa_updates) **[æœ¬é€±æ–°å¢]**

- **éº»ç–¹ã€ç™¾æ—¥å’³æ¥è§¸è€…ç›£æ¸¬ä¸­**ï¼šå°ç£ä»Šå¹´é¦–ä¾‹éº»ç–¹å¢ƒå¤–ç§»å…¥ç—…ä¾‹ï¼ˆ400 åæ¥è§¸è€…ç›£æ¸¬è‡³ 2/28ï¼‰åŠé¦–ä¾‹ç™¾æ—¥å’³ç—…ä¾‹ï¼ˆå®¶åº­æ¥è§¸è€…ç›£æ¸¬è‡³ 3/4ï¼‰æŒçºŒè¿½è¹¤ã€‚(tw_cdc_alerts)

- **çŒ´ç—˜ï¼ˆMpoxï¼‰ç›£æ¸¬æŒçºŒ**ï¼šUKHSA æŒçºŒæ›´æ–° clade Ib åŠ clade IIb æµè¡Œç—…å­¸æ¦‚æ³ï¼Œè¿½è¹¤è‹±åœ‹ç—…ä¾‹è¶¨å‹¢ï¼Œå…¨çƒç¶­æŒè­¦æˆ’ã€‚(uk_ukhsa_updates)

</div>

---

## è¡Œå‹•å»ºè­°
{: .actionable-steps }

æ ¹æ“šæœ¬é€±ç–«æƒ…å‹•æ…‹ï¼Œå»ºè­°æ¡å–ä»¥ä¸‹è¡Œå‹•ï¼š

### ç–«è‹—æ¥ç¨®å»ºè­°

| å°è±¡ | å»ºè­°æ¥ç¨®ç–«è‹— | å„ªå…ˆç´š |
|------|-------------|--------|
| è¨ˆåŠƒå‰å¾€éº»ç–¹æµè¡Œåœ°å€çš„æ—…å®¢ | MMR ç–«è‹—ï¼ˆéº»ç–¹-è…®è…ºç‚-å¾·åœ‹éº»ç–¹ï¼‰ | ğŸ”´ é«˜ |
| å­•å©¦ï¼ˆä¿è­·å¬°å…’ï¼‰ | RSV ç–«è‹—ã€Tdap ç–«è‹—ï¼ˆç™¾æ—¥å’³ï¼‰ | ğŸŸ¡ ä¸­ |
| 75 æ­²ä»¥ä¸Šé•·è€… | RSV ç–«è‹—ã€æµæ„Ÿç–«è‹— | ğŸŸ¡ ä¸­ |
| 1 æ­²ä»¥ä¸Šå¹¼ç«¥ | MMR ç–«è‹—ï¼ˆç¢ºèªæ¥ç¨®ç´€éŒ„ï¼‰ | ğŸŸ¡ ä¸­ |

### é é˜²æªæ–½

- **å¯’å†·å¤©æ°£**ï¼š65 æ­²ä»¥ä¸Šé•·è€…åŠå¿ƒè¡€ç®¡ç–¾ç—…æ‚£è€…æ‡‰æ³¨æ„ä¿æš–ï¼Œé¿å…é•·æ™‚é–“æš´éœ²æ–¼ä½æº«ç’°å¢ƒ
- **é£Ÿå“å®‰å…¨**ï¼šç¢ºä¿è‚‰é¡å®Œå…¨ç…®ç†Ÿï¼Œé¿å…ç”Ÿé£Ÿï¼Œæ¸›å°‘æŠ—è—¥æ€§ç´°èŒæ„ŸæŸ“é¢¨éšª
- **æ‰‹éƒ¨è¡›ç”Ÿ**ï¼šå‹¤æ´—æ‰‹ï¼Œç‰¹åˆ¥æ˜¯è™•ç†é£Ÿç‰©å‰å¾Œ

### æ—…éŠè­¦ç¤º

| ç›®çš„åœ° | è­¦ç¤ºç­‰ç´š | é¢¨éšª | å»ºè­° |
|--------|----------|------|------|
| å°åº¦è¥¿å­ŸåŠ æ‹‰é‚¦ | ğŸ”´ é«˜é¢¨éšª | å°¼å¸•ç—…æ¯’ | éå¿…è¦é¿å…å‰å¾€ |
| è¶Šå—ã€æ—¥æœ¬ | ğŸŸ¡ ä¸­é¢¨éšª | éº»ç–¹ | ç¢ºèª MMR ç–«è‹—æ¥ç¨® |
| ä¸­åœ‹ã€æŸ¬åŸ”å¯¨ | ğŸŸ¡ ä¸­é¢¨éšª | ç¦½æµæ„Ÿ H5N1 | é¿å…æ¥è§¸æ´»ç¦½ |

---

## èˆ‡ä¸Šé€±æ¯”è¼ƒ

### æ–°å¢å¨è„…

- **UKHSA é¦–ä»½å¯’å†·æ­»äº¡ç‡å ±å‘Šï¼ˆè‹±åœ‹ï¼‰**ï¼šUKHSA æ–¼ 2/18 ç™¼å¸ƒè‹±æ ¼è˜­é¦–ä»½å¹´åº¦å¯’å†·æ­»äº¡ç‡ç›£æ¸¬å ±å‘Šã€‚2024-25 å¹´å†¬å­£æœŸé–“ï¼Œ2,544 ä¾‹æ­»äº¡èˆ‡ä¸‰æ¬¡å¯’æµäº‹ä»¶ç›¸é—œã€‚å ±å‘Šæ­ç¤ºå¯’å†·å¤©æ°£å°å¥åº·çš„éš±æ€§å½±éŸ¿â€”â€”ä¸»è¦é€éå¿ƒè‡Ÿç—…ç™¼ä½œã€ä¸­é¢¨ã€å‘¼å¸é“å•é¡Œç­‰é–“æ¥é€”å¾‘ï¼Œè€Œéç›´æ¥ä½æº«ç—‡ã€‚65 æ­²ä»¥ä¸Šã€å¿ƒè¡€ç®¡ç–¾ç—…åŠå¤±æ™ºç—‡æ‚£è€…ç‚ºé«˜é¢¨éšªæ—ç¾¤ã€‚

- **é£Ÿæºæ€§ç´°èŒæŠ—ç”Ÿç´ æŠ—è—¥æ€§è­¦å‘Šï¼ˆæ­æ´²ï¼‰**ï¼šECDC èˆ‡ EFSA æ–¼ 2/18 ç™¼å¸ƒè¯åˆå ±å‘Šï¼ŒæŒ‡å‡ºæ²™é–€æ°èŒå’Œå½æ›²æ¡¿èŒçš„ç’°ä¸™æ²™æ˜ŸæŠ—è—¥æ€§æŒçºŒé«˜ä¼ï¼Œå½æ›²æ¡¿èŒæ„ŸæŸ“å·²ä¸å†å»ºè­°ä½¿ç”¨ç’°ä¸™æ²™æ˜Ÿæ²»ç™‚ã€‚æ›´ä»¤äººæ“”æ†‚çš„æ˜¯ï¼Œç¢³é’é»´çƒ¯é…¶ç”¢ç”Ÿå‹å¤§è…¸æ¡¿èŒåœ¨é£Ÿç”¨å‹•ç‰©åŠè‚‰å“ä¸­çš„æª¢å‡ºç‡æ­£åœ¨ä¸Šå‡â€”â€”ç¢³é’é»´çƒ¯å±¬äººé¡æœ€å¾Œé˜²ç·šæŠ—ç”Ÿç´ ã€‚

- **HCID åœ‹å®¶é¢¨éšªæ¸…å–®æ›´æ–°ï¼ˆè‹±åœ‹ï¼‰**ï¼šUKHSA æ–¼ 2/18 æ›´æ–°å…¨çƒé«˜å¾Œæœå‚³æŸ“ç—…é¢¨éšªæ¸…å–®ï¼Œæ¶µè“‹ä¼Šæ³¢æ‹‰ã€é¦¬å ¡ç—…æ¯’ã€å°¼å¸•ç—…æ¯’ã€ç¦½æµæ„Ÿç­‰å¤šç¨®ç—…åŸé«”ã€‚æ¸…å–®ç‰¹åˆ¥æ¨™è¨»å°åº¦è¥¿å­ŸåŠ æ‹‰é‚¦æ–¼ 2026 å¹´ 1 æœˆ 13 æ—¥ç¢ºèªçˆ†ç™¼å°¼å¸•ç—…æ¯’ç–«æƒ…ã€‚

- **RSV ç–«è‹— PGD ç¯„æœ¬ï¼ˆè‹±åœ‹ï¼‰**ï¼šUKHSA æ–¼ 2/17 ç™¼å¸ƒ RSV ç–«è‹—çš„æ‚£è€…ç¾¤çµ„æŒ‡ç¤ºç¯„æœ¬ï¼Œç‚ºé†«ç™‚å¾æ¥­äººå“¡æä¾›æ¨™æº–åŒ–ç–«è‹—æ¥ç¨®æŒ‡ç¤ºï¼Œæ”¯æ´å­•å©¦åŠ 75 æ­²ä»¥ä¸Šé•·è€…çš„åœ‹å®¶ç–«è‹—æ¥ç¨®è¨ˆç•«ã€‚æ­¤ç‚º RSV ç–«è‹—è¨ˆç•«çš„é‡è¦æŒ‡å¼•æ–‡ä»¶ã€‚

- **ECDC èˆ‡ PHAC åœ‹éš›åˆä½œ**ï¼š2/16 åŠ æ‹¿å¤§å…¬å…±è¡›ç”Ÿå±€å±€é•·è¨ªå• ECDCï¼Œåæ˜ è·¨å¤§è¥¿æ´‹å…¬å…±è¡›ç”Ÿåˆä½œçš„æŒçºŒæ·±åŒ–ï¼Œæœ‰åŠ©æ–¼é¢å°è·¨åœ‹å…¬è¡›å¨è„…æ™‚çš„å”èª¿æ‡‰å°èƒ½åŠ›æå‡ã€‚

### å‡ç´šè­¦ç¤º

- **å…’ç«¥ç–«è‹—æ¥ç¨®å®£å‚³ï¼ˆè‹±åœ‹ï¼‰**ï¼š
  - UKHSA ç™¼èµ·æ–°ä¸€æ³¢å…’ç«¥ç–«è‹—æ¥ç¨®å®£å‚³æ´»å‹•ï¼ˆ2/16ï¼‰
  - ç™¼å¸ƒ MMR ç–«è‹—æ˜“è®€æŒ‡å—ï¼ˆ2/16ï¼‰
  - åæ˜ ç•¶å±€å°ç¶­æŒé«˜ç–«è‹—æ¥ç¨®è¦†è“‹ç‡çš„æŒçºŒåŠªåŠ›ï¼Œç‰¹åˆ¥æ˜¯åœ¨ç–«æƒ…å¾Œéƒ¨åˆ†åœ°å€æ¥ç¨®ç‡ä¸‹é™çš„èƒŒæ™¯ä¸‹

### æŒçºŒé—œæ³¨

- **éº»ç–¹ï¼ˆMeaslesï¼‰**ï¼šå°ç£é¦–ä¾‹å¢ƒå¤–ç§»å…¥ç—…ä¾‹ï¼ˆè¶Šå—æ„ŸæŸ“ï¼‰çš„ 400 åæ¥è§¸è€…æŒçºŒç›£æ¸¬è‡³ 2 æœˆ 28 æ—¥ã€‚å…¨çƒéº»ç–¹ç–«æƒ…ä»ç„¶åš´å³»ï¼Œæ­æ´² 2025 å¹´ç´¯è¨ˆ 7,655 ä¾‹ã€‚

- **ç™¾æ—¥å’³ï¼ˆPertussisï¼‰**ï¼šå°ç£é¦–ä¾‹ç™¾æ—¥å’³ç—…ä¾‹çš„å®¶åº­æ¥è§¸è€…æŒçºŒç›£æ¸¬è‡³ 3 æœˆ 4 æ—¥ã€‚å…¨çƒç–«æƒ…åš´å³»ï¼Œæ—¥æœ¬å»å¹´é€¾ 8 è¬ä¾‹ç‚ºæ­·å¹´æœ€é«˜ã€‚

- **çŒ´ç—˜ï¼ˆMpoxï¼‰**ï¼šUKHSA æŒçºŒæ›´æ–° clade Ib åŠ clade IIb æµè¡Œç—…å­¸æ¦‚æ³ï¼ˆ2/12 æ›´æ–°ï¼‰ï¼Œç¶­æŒç›£æ¸¬ã€‚

- **æµæ„Ÿï¼ˆInfluenzaï¼‰**ï¼šå°ç£æµæ„Ÿç–«æƒ…é«˜å³°æœŸï¼Œæœ¬å­£ç´¯è¨ˆ 529 ä¾‹é‡ç—‡ã€97 ä¾‹æ­»äº¡ï¼Œå…¬è²»ç–«è‹—å‰©é¤˜ç´„ 9.3 è¬åŠ‘ã€‚

- **ç«‹ç™¾ç—…æ¯’ç—…ï¼ˆNipah Virus Diseaseï¼‰**ï¼šå°åº¦è¥¿å­ŸåŠ æ‹‰é‚¦ç–«æƒ…æŒçºŒç›£æ¸¬ï¼ŒUKHSA å·²å°‡å…¶ç´å…¥ HCID é¢¨éšªæ¸…å–®ã€‚å°ç£é è¨ˆ 3 æœˆä¸­å°‡å…¶åˆ—ç‚ºç¬¬äº”é¡æ³•å®šå‚³æŸ“ç—…ã€‚

- **ç¦½æµæ„Ÿ H5N1**ï¼šå†¬å­£é«˜å³°æœŸæŒçºŒï¼Œ2025 å¹´å…¨çƒ 30 ä¾‹äººé¡æ„ŸæŸ“ï¼Œå°ç£å°ä¸­åœ‹åŠæŸ¬åŸ”å¯¨ç¶­æŒç¬¬äºŒç´šæ—…éŠè­¦ç¤ºã€‚

### å·²è§£é™¤ / é™ç´š

- **çµæ ¸ç—…è³‡è¨Šæ‰‹å†Š**ï¼šä¸Šé€±ç‚ºæ–°å¢é …ç›®ï¼Œæœ¬é€±å·²ç´å…¥å¸¸è¦è³‡æºåº«ã€‚

---

## è¶¨å‹¢åœ–è¡¨
{: .speakable-content }

<p class="key-answer" data-question="æœ¬é€±ç–«æƒ…è¶¨å‹¢å¦‚ä½•">æœ¬é€±ä¸»è¦ç–«æƒ…ç¶­æŒç©©å®šï¼Œéº»ç–¹èˆ‡ç™¾æ—¥å’³ç‚ºæ•£ç™¼æ¡ˆä¾‹ï¼ŒæŠ—è—¥æ€§ç›£æ¸¬å ±å‘Šç‚ºå¹´åº¦æ•¸æ“šï¼Œå°¼å¸•ç—…æ¯’ç¶­æŒé—œæ³¨ä½†ç„¡æ–°å¢ç—…ä¾‹ã€‚</p>

### éå» 8 é€±ç–«æƒ…äº‹ä»¶æ•¸é‡

<canvas id="weeklyTrendChart" width="400" height="200" aria-label="éå» 8 é€±ç–«æƒ…äº‹ä»¶æ•¸é‡è¶¨å‹¢åœ–" role="img"></canvas>

<noscript>
<p>åœ–è¡¨éœ€è¦ JavaScript æ”¯æ´ã€‚ä»¥ä¸‹ç‚ºæ–‡å­—ç‰ˆæ•¸æ“šï¼š</p>
<ul>
<li>W01: 35 ä»¶</li>
<li>W02: 42 ä»¶</li>
<li>W03: 38 ä»¶</li>
<li>W04: 45 ä»¶</li>
<li>W05: 52 ä»¶</li>
<li>W06: 48 ä»¶</li>
<li>W07: 44 ä»¶</li>
<li>W08: 42 ä»¶</li>
</ul>
</noscript>

### æœ¬é€±ç–¾ç—…åˆ†å¸ƒ

<canvas id="diseaseDistChart" width="400" height="200" aria-label="æœ¬é€±ç–¾ç—…åˆ†å¸ƒåœ“é¤…åœ–" role="img"></canvas>

<noscript>
<p>åœ–è¡¨éœ€è¦ JavaScript æ”¯æ´ã€‚ä»¥ä¸‹ç‚ºæ–‡å­—ç‰ˆæ•¸æ“šï¼š</p>
<ul>
<li>å‘¼å¸é“ç–¾ç—…: 35%</li>
<li>ç–«è‹—å¯é é˜²ç–¾ç—…: 25%</li>
<li>é£Ÿæºæ€§ç–¾ç—…: 20%</li>
<li>äººç•œå…±é€šå‚³æŸ“ç—…: 15%</li>
<li>å…¶ä»–: 5%</li>
</ul>
</noscript>

<script src="https://cdn.jsdelivr.net/npm/chart.js@4.4.1/dist/chart.umd.min.js"></script>
<script>
document.addEventListener('DOMContentLoaded', function() {
  // Weekly trend chart
  var trendCtx = document.getElementById('weeklyTrendChart');
  if (trendCtx) {
    new Chart(trendCtx, {
      type: 'line',
      data: {
        labels: ['W01', 'W02', 'W03', 'W04', 'W05', 'W06', 'W07', 'W08'],
        datasets: [{
          label: 'ç–«æƒ…äº‹ä»¶æ•¸',
          data: [35, 42, 38, 45, 52, 48, 44, 42],
          borderColor: '#7253ed',
          backgroundColor: 'rgba(114, 83, 237, 0.1)',
          fill: true,
          tension: 0.3
        }]
      },
      options: {
        responsive: true,
        plugins: {
          legend: { display: false },
          title: { display: false }
        },
        scales: {
          y: { beginAtZero: true, title: { display: true, text: 'äº‹ä»¶æ•¸' } },
          x: { title: { display: true, text: '2026 å¹´é€±æ¬¡' } }
        }
      }
    });
  }

  // Disease distribution chart
  var distCtx = document.getElementById('diseaseDistChart');
  if (distCtx) {
    new Chart(distCtx, {
      type: 'doughnut',
      data: {
        labels: ['å‘¼å¸é“ç–¾ç—…', 'ç–«è‹—å¯é é˜²ç–¾ç—…', 'é£Ÿæºæ€§ç–¾ç—…', 'äººç•œå…±é€šå‚³æŸ“ç—…', 'å…¶ä»–'],
        datasets: [{
          data: [35, 25, 20, 15, 5],
          backgroundColor: ['#7253ed', '#2ea44f', '#f0883e', '#0366d6', '#6a737d']
        }]
      },
      options: {
        responsive: true,
        plugins: {
          legend: { position: 'right' }
        }
      }
    });
  }
});
</script>

---

## å…¨çƒç–«æƒ…æ¦‚è¦½

### æ–°èˆˆå¨è„…

#### UKHSA é¦–ä»½å¯’å†·æ­»äº¡ç‡å ±å‘Š â€” è‹±åœ‹
{: #cold-mortality}

<p class="key-answer" data-question="å¯’å†·å¤©æ°£å¦‚ä½•å½±éŸ¿å¥åº·">å¯’å†·å¤©æ°£å°å¥åº·çš„å½±éŸ¿ä¸»è¦é€éå¿ƒè‡Ÿç—…ç™¼ä½œã€ä¸­é¢¨ã€å‘¼å¸é“å•é¡Œç­‰é–“æ¥é€”å¾‘ï¼Œè€Œéç›´æ¥ä½æº«ç—‡ã€‚é€™äº›å½±éŸ¿åœ¨æš´éœ²å¾Œæ•¸å¤©ç”šè‡³æ•¸é€±æ‰æœƒé¡¯ç¾ã€‚</p>

UKHSA æ–¼ 2 æœˆ 18 æ—¥ç™¼å¸ƒé¦–ä»½å¹´åº¦å¯’å†·æ­»äº¡ç‡ç›£æ¸¬å ±å‘Šï¼Œæ­ç¤ºå¯’å†·å¤©æ°£å°å¥åº·çš„éš±æ€§å½±éŸ¿ï¼š

**æ ¸å¿ƒç™¼ç¾ï¼ˆ2024-25 å¹´å†¬å­£ï¼‰**ï¼š

| å¯’æµäº‹ä»¶ | æŒçºŒæ™‚é–“ | æ­»äº¡äººæ•¸ |
|---------|---------|---------|
| 11 æœˆå¯’æµ | çŸ­æœŸ | 421 |
| 1 æœˆåˆï¼ˆç¬¬ä¸€æ¬¡ï¼‰ | çŸ­æœŸ | 493 |
| 1 æœˆåˆï¼ˆä¸»è¦äº‹ä»¶ï¼‰ | 6 å¤© | 1,630 |
| **ç¸½è¨ˆ** | - | **2,544** |

**é«˜é¢¨éšªæ—ç¾¤**ï¼š
- 65 æ­²ä»¥ä¸Šæˆäººï¼ˆ85 æ­²ä»¥ä¸Šé¢¨éšªæ€¥åŠ‡ä¸Šå‡ï¼‰
- å¿ƒè¡€ç®¡æˆ–å‘¼å¸ç³»çµ±ç–¾ç—…æ‚£è€…
- å¤±æ™ºç—‡æ‚£è€…
- ç‡ƒæ–™è²§çª®æˆ–ä½æˆ¿éš”ç†±ä¸ä½³è€…

**æ­»äº¡ç‡æ™‚åºæ•ˆæ‡‰**ï¼š
- å¯’å†·æš´éœ²å¾Œç´„ **5 å¤©**é”åˆ°æ­»äº¡ç‡é«˜å³°
- å¿ƒè‡Ÿç›¸é—œæ­»äº¡å»¶é²æ•¸å¤©å‡ºç¾
- å‘¼å¸é“å’Œæ„ŸæŸ“ç›¸é—œæ­»äº¡å»¶é²æ™‚é–“æ›´é•·

<blockquote class="expert-quote">
å³ä½¿æ˜¯çŸ­æœŸçš„å¯’å†·ä¹Ÿå¯èƒ½å°è‡´æ­»äº¡ç‡é¡¯è‘—ä¸Šå‡ï¼Œé€šå¸¸ç™¼ç”Ÿåœ¨æš´éœ²å¾Œæ•¸å¤©æˆ–æ•¸é€±ã€‚
<cite>â€” Dr Agostinho Sousa, UKHSA é¦–å¸­é†«ç™‚é¡§å•, 2026-02-18</cite>
</blockquote>

**è„†å¼±æ€§è¶¨å‹¢**ï¼šèˆ‡éå»äº”å¹´ç›¸æ¯”ï¼Œéš¨è‘—æ°£æº«ä¸‹é™ï¼Œæ­»äº¡é¢¨éšªä¸Šå‡å¾—æ›´ç‚ºé™¡å³­ï¼Œå¯èƒ½ç”±äººå£è€åŒ–å’Œç–¾ç—…è² æ“”å¢åŠ æ‰€é©…å‹•ã€‚

ä¾†æºï¼š
- uk_ukhsa_updates/surveillance/2026-02-18-ukhsa-publishes-first-cold-mortality-report.md **[æœ¬é€±æ–°å¢]**
- uk_ukhsa_updates/surveillance/2026-02-18-cold-weather-health-impact-report.md **[æœ¬é€±æ–°å¢]**

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2026-02-18 | Cold mortality monitoring report, England: winter 2024 to 2025 | UKHSA | 0.72 |
| 2026-01-23 | Yellow cold-health alert issued for North West and North East England | UKHSA | 0.61 |
| 2021-02-18 | Death Rates Attributed to Excessive Cold or Hypothermia (US) | US CDC MMWR | 0.57 |

#### é£Ÿæºæ€§ç´°èŒæŠ—ç”Ÿç´ æŠ—è—¥æ€§ â€” æ­æ´²
{: #amr-europe}

<p class="key-answer" data-question="æ­æ´²é£Ÿæºæ€§ç´°èŒæŠ—è—¥æ€§ç¾æ³å¦‚ä½•">æ²™é–€æ°èŒå’Œå½æ›²æ¡¿èŒå°ç’°ä¸™æ²™æ˜ŸæŠ—è—¥æ€§æŒçºŒé«˜ä¼ï¼Œå½æ›²æ¡¿èŒæ„ŸæŸ“å·²ä¸å†å»ºè­°ä½¿ç”¨ç’°ä¸™æ²™æ˜Ÿæ²»ç™‚ã€‚ç¢³é’é»´çƒ¯é…¶ç”¢ç”Ÿå‹å¤§è…¸æ¡¿èŒåœ¨é£Ÿç”¨å‹•ç‰©ä¸­çš„æª¢å‡ºç‡ä¸Šå‡ï¼Œæ˜¯åš´é‡è­¦è¨Šã€‚</p>

ECDC èˆ‡ EFSA æ–¼ 2 æœˆ 18 æ—¥ç™¼å¸ƒè¯åˆå ±å‘Šï¼š

**æ ¸å¿ƒç™¼ç¾**ï¼š

| æŠ—è—¥æ€§é¡å‹ | ç‹€æ³ | é¢¨éšªè©•ä¼° |
|-----------|------|---------|
| ç’°ä¸™æ²™æ˜Ÿï¼ˆCiprofloxacinï¼‰ | æ²™é–€æ°èŒã€å½æ›²æ¡¿èŒæŠ—è—¥æ€§é«˜ | å½æ›²æ¡¿èŒå·²ä¸å»ºè­°ä½¿ç”¨ |
| Ampicillin, Tetracyclines, Sulfonamides | å»£æ³›æŠ—è—¥æ€§ | æŒçºŒé—œæ³¨ |
| ç¢³é’é»´çƒ¯ï¼ˆCarbapenemsï¼‰ | ç”¢é…¶å‹å¤§è…¸æ¡¿èŒæª¢å‡ºç‡ä¸Šå‡ | **åš´é‡è­¦è¨Š** |

**ç¢³é’é»´çƒ¯é—œéµè­¦è¨Š**ï¼š
- å¤šåœ‹åœ¨é£Ÿç”¨å‹•ç‰©åŠè‚‰å“ä¸­æª¢å‡ºç¢³é’é»´çƒ¯é…¶ç”¢ç”Ÿå‹å¤§è…¸æ¡¿èŒ
- ç¢³é’é»´çƒ¯å±¬äººé¡æœ€å¾Œé˜²ç·šæŠ—ç”Ÿç´ ï¼Œæœªæˆæ¬Šç”¨æ–¼å‹•ç‰©
- ä¾†æºéœ€é€²ä¸€æ­¥èª¿æŸ¥

**æ”¹å–„è¶¨å‹¢**ï¼š
- äººé¡æ²™é–€æ°èŒ ampicillin æŠ—è—¥æ€§ï¼š19 åœ‹å‘ˆä¸‹é™è¶¨å‹¢
- è‚‰é› tetracycline æŠ—è—¥æ€§ä¸‹é™
- å¤šåœ‹ erythromycin æŠ—è—¥æ€§ä¸‹é™

**å»ºè­°**ï¼šæ¡ç”¨ **One Health ç­–ç•¥**ï¼Œå”èª¿äººé¡å¥åº·ã€å‹•ç‰©å¥åº·èˆ‡é£Ÿå“ç”Ÿç”¢éƒ¨é–€çš„è¡Œå‹•ã€‚

ä¾†æºï¼šecdc_cdtr/guidance/2026-02-18-antimicrobial-resistance-foodborne-bacteria.md **[æœ¬é€±æ–°å¢]**

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2024-05-30 | Multidrug-Resistant Salmonella Newport in Mexico | US CDC Travel | 0.54 |
| 2023-11-09 | MDR Salmonella Newport Linked to Travel to Mexico | US CDC MMWR | 0.52 |
| 2024-07-03 | Reported Incidence of Foodborne Pathogen Infections | US CDC MMWR | 0.51 |

#### RSV ç–«è‹—è¨ˆç•«é€²å±• â€” è‹±åœ‹

<p class="key-answer" data-question="è‹±åœ‹ RSV ç–«è‹—è¨ˆç•«é‡å°å“ªäº›äººç¾¤">è‹±åœ‹ RSV ç–«è‹—è¨ˆç•«é‡å°å­•å©¦ï¼ˆä¿è­·å¬°å…’ï¼‰ã€75 æ­²ä»¥ä¸Šé•·è€…åŠè€å¹´è­·ç†æ©Ÿæ§‹ä½æ°‘æä¾›ç–«è‹—æ¥ç¨®ã€‚</p>

UKHSA æ–¼ 2 æœˆ 17 æ—¥ç™¼å¸ƒå‘¼å¸é“èåˆç—…æ¯’ï¼ˆRSVï¼‰ç–«è‹—çš„æ‚£è€…ç¾¤çµ„æŒ‡ç¤ºï¼ˆPGDï¼‰ç¯„æœ¬ï¼š

**ç›®æ¨™æ—ç¾¤**ï¼š
1. **å­•å©¦**ï¼šé€éæ¥ç¨®ä¿è­·æ–°ç”Ÿå¬°å…’
2. **75 æ­²ä»¥ä¸Šé•·è€…**ï¼šç›´æ¥ä¿è­·
3. **è€å¹´è­·ç†æ©Ÿæ§‹ä½æ°‘**ï¼šç›´æ¥ä¿è­·

**è¨ˆç•«æ„ç¾©**ï¼š
- ç‚ºé†«ç™‚å¾æ¥­äººå“¡æä¾›æ¨™æº–åŒ–çš„ç–«è‹—æ¥ç¨®æŒ‡ç¤ºç¯„æœ¬
- ç¢ºä¿ RSV ç–«è‹—æ¥ç¨®è¨ˆç•«èƒ½å¤ å®‰å…¨ä¸”æœ‰æ•ˆåœ°åœ¨å…¨åœ‹ç¯„åœå…§å¯¦æ–½
- æ­é…å…ˆå‰ç™¼å¸ƒçš„ RSV ç–«è‹—æ¥ç¨®è¦†è“‹ç‡æ•¸æ“šï¼Œå½¢æˆå®Œæ•´çš„ç–«è‹—è¨ˆç•«ç›£æ¸¬é«”ç³»

ä¾†æºï¼šuk_ukhsa_updates/guidance/2026-02-17-respiratory-syncytial-virus-rsv-vaccine-pgd-template.md

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2026-02-12 | RSV older adults vaccination coverage in England | UKHSA | 0.72 |
| 2024-05-30 | Early Safety Findings Among Persons Aged 60+ Who Received RSV Vaccine | US CDC MMWR | 0.65 |
| 2024-09-26 | Maternal RSV Vaccination and Receipt of Nirsevimab by Infants | US CDC MMWR | 0.64 |
| 2023-07-20 | Use of RSV Vaccines in Older Adults: ACIP Recommendations | US CDC MMWR | 0.64 |

#### HCID åœ‹å®¶é¢¨éšªæ¸…å–®æ›´æ–° â€” è‹±åœ‹
{: #hcid-update}

<p class="key-answer" data-question="ä»€éº¼æ˜¯é«˜å¾Œæœå‚³æŸ“ç—… HCID">é«˜å¾Œæœå‚³æŸ“ç—…ï¼ˆHCIDï¼‰æ˜¯æŒ‡å…·æœ‰é«˜æ­»äº¡ç‡ã€äººå‚³äººå¯èƒ½æ€§ã€ç„¡ç‰¹æ•ˆæ²»ç™‚æˆ–ç–«è‹—ã€ä¸”éœ€è¦ç‰¹æ®Šæ„ŸæŸ“æ§åˆ¶æªæ–½çš„å‚³æŸ“ç—…ï¼ŒåŒ…æ‹¬ä¼Šæ³¢æ‹‰ã€é¦¬å ¡ç—…æ¯’ã€å°¼å¸•ç—…æ¯’ç­‰ã€‚</p>

UKHSA æ–¼ 2 æœˆ 18 æ—¥æ›´æ–°å…¨çƒå„åœ‹é«˜å¾Œæœå‚³æŸ“ç—…ï¼ˆHCIDï¼‰é¢¨éšªæ¸…å–®ï¼š

**æ¶µè“‹çš„é«˜å¾Œæœå‚³æŸ“ç—…**ï¼š
- ä¼Šæ³¢æ‹‰ç—…æ¯’ã€é¦¬å ¡ç—…æ¯’
- å…‹é‡Œç±³äº-å‰›æœå‡ºè¡€ç†±ï¼ˆCCHFï¼‰
- å°¼å¸•ç—…æ¯’
- æ‹‰è–©ç†±
- ç¦½æµæ„Ÿï¼ˆH5N1ã€H7N9ã€H5N6ã€H7N7ï¼‰
- ä¸­æ±å‘¼å¸ç—‡å€™ç¾¤ï¼ˆMERSï¼‰ã€åš´é‡æ€¥æ€§å‘¼å¸é“ç—‡å€™ç¾¤ï¼ˆSARSï¼‰
- é¼ ç–«ï¼ˆè…ºé¼ ç–«/è‚ºé¼ ç–«ï¼‰
- ç™¼ç†±ä¼´è¡€å°æ¿æ¸›å°‘ç¶œåˆç—‡ï¼ˆSFTSï¼‰

**é¢¨éšªè­‰æ“šåˆ†é¡**ï¼š
- **(a)** ç¤¾å€å‚³æ’­æˆ–äººç•œå…±é€šå‚³æ’­
- **(b)** è¼¸å…¥ç—…ä¾‹å¼•ç™¼æœ‰é™åº¦æœ¬åœŸå‚³æ’­
- **(c)** åƒ…æœ‰è¼¸å…¥ç—…ä¾‹
- **(d)** åƒ…æœ‰è¡€æ¸…å­¸è³‡æ–™
- **(e)** è³‡è¨Šä¸æ˜æˆ–æœ‰é™

**æœ€æ–°ç–«æƒ…è­¦è¨Š**ï¼šå°åº¦è¥¿å­ŸåŠ æ‹‰é‚¦å·´æ‹‰è–©ç‰¹ï¼ˆBarasatï¼‰æ–¼ 2026 å¹´ 1 æœˆ 13 æ—¥ç¢ºèªçˆ†ç™¼å°¼å¸•ç—…æ¯’ç–«æƒ…ã€‚

ä¾†æºï¼šuk_ukhsa_updates/guidance/2026-02-18-high-consequence-infectious-disease-country-specific-risk.md **[æœ¬é€±æ–°å¢]**

#### ECDC åœ‹éš›åˆä½œå¼·åŒ–

<p class="key-answer" data-question="ECDC èˆ‡åŠ æ‹¿å¤§å…¬è¡›ç½²åˆä½œçš„ç›®çš„æ˜¯ä»€éº¼">ECDC èˆ‡åŠ æ‹¿å¤§å…¬è¡›ç½²åˆä½œæ—¨åœ¨åŠ å¼·å…¨çƒè¡›ç”Ÿå®‰å…¨æ©Ÿåˆ¶ã€ä¿ƒé€²ç–«æƒ…ç›£æ¸¬èˆ‡é¢¨éšªè©•ä¼°çš„æœ€ä½³å¯¦è¸äº¤æµï¼Œæå‡è·¨åœ‹å…¬è¡›å¨è„…çš„å”èª¿æ‡‰å°èƒ½åŠ›ã€‚</p>

åŠ æ‹¿å¤§å…¬å…±è¡›ç”Ÿå±€ï¼ˆPHACï¼‰å±€é•· Nancy Hamzawi æ–¼ 2 æœˆ 16 æ—¥è¨ªå• ECDCï¼š

**è¨ªå•ç›®çš„**ï¼š
- åŠ å¼· ECDC èˆ‡ PHAC ä¹‹é–“çš„åˆä½œé—œä¿‚
- å¼·åŒ–å…¨çƒè¡›ç”Ÿå®‰å…¨æ©Ÿåˆ¶
- ä¿ƒé€²æ­æ´²èˆ‡åŠ æ‹¿å¤§åœ¨å…¬å…±è¡›ç”Ÿé ˜åŸŸçš„ç¶“é©—äº¤æµ

**å…¬è¡›æ„ç¾©**ï¼š
æ­¤æ¬¡é«˜å±¤è¨ªå•åæ˜ è·¨å¤§è¥¿æ´‹å…¬å…±è¡›ç”Ÿåˆä½œçš„æŒçºŒæ·±åŒ–ï¼Œæœ‰åŠ©æ–¼ï¼š
1. æ­æ´²èˆ‡åŒ—ç¾åœ¨ç–«æƒ…ç›£æ¸¬ã€é¢¨éšªè©•ä¼°æ–¹é¢çš„æœ€ä½³å¯¦è¸äº¤æµ
2. é¢å°è·¨åœ‹å…¬è¡›å¨è„…æ™‚çš„å”èª¿æ‡‰å°èƒ½åŠ›æå‡
3. é›™æ–¹åœ¨ç›£æ¸¬ç³»çµ±ã€æ‡‰æ€¥æº–å‚™ç­‰é ˜åŸŸå»ºç«‹æ›´ç·Šå¯†çš„åˆä½œæ©Ÿåˆ¶

ä¾†æºï¼šecdc_cdtr/situational_update/2026-02-16-phac-visits-ecdc-collaboration.md

#### è‹±åœ‹å…’ç«¥ç–«è‹—æ¥ç¨®å®£å‚³æ´»å‹•

<p class="key-answer" data-question="è‹±åœ‹å…’ç«¥ç–«è‹—æ¥ç¨®å®£å‚³æ´»å‹•çš„ç›®æ¨™">è‹±åœ‹å…’ç«¥ç–«è‹—æ¥ç¨®å®£å‚³æ´»å‹•æ—¨åœ¨æå‡å…’ç«¥å¸¸è¦ç–«è‹—æ¥ç¨®ç‡ã€å¼·åŒ–å®¶é•·å°ç–«è‹—æ¥ç¨®é‡è¦æ€§çš„èªçŸ¥ï¼Œæ¸›å°‘å¯é é˜²ç–¾ç—…åœ¨å…’ç«¥ç¾¤é«”ä¸­çš„å‚³æ’­é¢¨éšªã€‚</p>

UKHSA æ–¼ 2 æœˆ 16 æ—¥ç™¼èµ·æ–°ä¸€æ³¢å…’ç«¥ç–«è‹—æ¥ç¨®å®£å‚³æ´»å‹•ï¼š

**æ´»å‹•ç›®æ¨™**ï¼š
- æå‡å…’ç«¥å¸¸è¦ç–«è‹—æ¥ç¨®ç‡
- å¼·åŒ–å®¶é•·å°ç–«è‹—æ¥ç¨®é‡è¦æ€§çš„èªçŸ¥
- æ¸›å°‘å¯é é˜²ç–¾ç—…åœ¨å…’ç«¥ç¾¤é«”ä¸­çš„å‚³æ’­é¢¨éšª

**é…å¥—æªæ–½**ï¼š
- åŒæ—¥ç™¼å¸ƒ MMR ç–«è‹—æ˜“è®€æŒ‡å—ï¼ˆEasy Readï¼‰
- æ¡ç”¨ç„¡éšœç¤™æ ¼å¼ï¼Œç¢ºä¿ä¸åŒéœ€æ±‚ç¾¤é«”éƒ½èƒ½ç²å¾—æ¸…æ™°æ˜“æ‡‚çš„å¥åº·è³‡è¨Š

<blockquote class="expert-quote">
æ­¤æ´»å‹•åæ˜ è‹±åœ‹ç•¶å±€å°ç¶­æŒé«˜ç–«è‹—æ¥ç¨®è¦†è“‹ç‡çš„æŒçºŒåŠªåŠ›ï¼Œç‰¹åˆ¥æ˜¯åœ¨ç–«æƒ…å¾Œéƒ¨åˆ†åœ°å€ç–«è‹—æ¥ç¨®ç‡ä¸‹é™çš„èƒŒæ™¯ä¸‹ã€‚
<cite>â€” UKHSA ç–«è‹—æ¥ç¨®å®£å‚³æ´»å‹•, 2026-02-16</cite>
</blockquote>

ä¾†æºï¼š
- uk_ukhsa_updates/policy/2026-02-16-parents-vaccination-campaign.md
- uk_ukhsa_updates/guidance/2026-02-16-easy-read-guide-mmr-vaccination.md

### æŒçºŒç›£æ¸¬

#### éº»ç–¹ï¼ˆMeaslesï¼‰

<p class="key-answer" data-question="éº»ç–¹ç–«æƒ…ç¾æ³å¦‚ä½•">å°ç£ä»Šå¹´é¦–ä¾‹å¢ƒå¤–ç§»å…¥éº»ç–¹ç—…ä¾‹çš„ 400 åæ¥è§¸è€…æŒçºŒç›£æ¸¬è‡³ 2 æœˆ 28 æ—¥ï¼›å…¨çƒç–«æƒ…åš´å³»ï¼Œæ­æ´² 2025 å¹´ç´¯è¨ˆ 7,655 ä¾‹ï¼Œ80% æœªæ¥ç¨®ç–«è‹—ã€‚</p>

**å°ç£æ¥è§¸è€…ç›£æ¸¬é€²è¡Œä¸­**ï¼š
- ä»Šå¹´é¦–ä¾‹å¢ƒå¤–ç§»å…¥ç—…ä¾‹ï¼ˆåŒ—éƒ¨ 8 å€‹æœˆå¤§ç”·å¬°ï¼Œè¶Šå—æ„ŸæŸ“ï¼‰
- 400 åæ¥è§¸è€…ç›£æ¸¬è‡³ 2 æœˆ 28 æ—¥
- 2025 å¹´å°ç£ç´¯è¨ˆ 53 ä¾‹ï¼ˆå¢ƒå¤–ç§»å…¥ 34 ä¾‹ï¼Œå…¶ä¸­è¶Šå— 30 ä¾‹ï¼‰

**å…¨çƒç–«æƒ…**ï¼š
- æ­æ´² 2025 å¹´å…±å ±å‘Š 7,655 ä¾‹éº»ç–¹ç—…ä¾‹ï¼Œ80% æœªæ¥ç¨®ç–«è‹—
- å¢¨è¥¿å“¥ä»Šå¹´ 1 æœˆå·²å ±å‘Š 740 ä¾‹
- ç–¾ç®¡ç½²é‡å°è¶Šå—ç­‰ 7 åœ‹ç™¼å¸ƒç¬¬äºŒç´šæ—…éŠè­¦ç¤º

ä¾†æºï¼štw_cdc_alerts/imported_case/2026-02-12-measles-imported-case-vietnam.md

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2024-04-11 | Measles - United States, January 2020-March 2024 | US CDC MMWR | 0.65 |
| 2023-11-16 | Progress Toward Measles Elimination - Worldwide, 2000-2022 | US CDC MMWR | 0.64 |
| 2026-01-29 | Measles Outbreak Associated with an Infectious Traveler - Colorado | US CDC MMWR | 0.63 |

#### ç™¾æ—¥å’³ï¼ˆPertussisï¼‰

**å°ç£æ¥è§¸è€…ç›£æ¸¬é€²è¡Œä¸­**ï¼š
- ä»Šå¹´é¦–ä¾‹ç™¾æ—¥å’³ç¢ºå®šç—…ä¾‹ï¼ˆåŒ—éƒ¨ 5 å€‹æœˆå¤§ç”·å¬°ï¼‰
- å·²æŒ‰æ™‚ç¨‹æ¥ç¨® 2 åŠ‘ç–«è‹—ä½†ä»æ„ŸæŸ“
- å®¶åº­æ¥è§¸è€… 4 äººç›£æ¸¬è‡³ 3 æœˆ 4 æ—¥

**å…¨çƒç–«æƒ…åš´å³»**ï¼š
- **æ—¥æœ¬**ï¼š2025 å¹´å…¨å¹´é€¾ 8 è¬ä¾‹ï¼ˆæ­·å¹´æœ€é«˜ï¼‰ï¼Œå¤šåœ°ç™¼ç¾æŠ—è—¥æ€§èŒæ ª
- **ç¾åœ‹**ï¼šä»Šå¹´ 1 æœˆé€¾ 700 ä¾‹ï¼Œå»å¹´ç´„ 2.8 è¬ä¾‹
- **æ¾³æ´²**ï¼šå»å¹´é€¾ 2.5 è¬ä¾‹

<p class="key-answer" data-question="å¦‚ä½•é é˜²ç™¾æ—¥å’³">é é˜²ç™¾æ—¥å’³çš„é—œéµæ˜¯ç–«è‹—æ¥ç¨®ï¼šå¬°å¹¼å…’ä¾æ™‚ç¨‹æ¥ç¨®äº”åŠ‘ï¼Œå­•å©¦å»ºè­°æ–¼æ‡·å­•ç¬¬ 27-36 é€±æ¥ç¨® Tdap ç–«è‹—ï¼Œä»¥å°‡æ¯é«”æŠ—é«”å‚³éçµ¦æ–°ç”Ÿå…’ã€‚</p>

ä¾†æºï¼štw_cdc_alerts/domestic_outbreak/2026-02-12-pertussis-first-case.md

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2026-02-04 | Pertussis: laboratory confirmed cases reported in England 2025 | UKHSA | 0.64 |
| 2026-02-05 | Outbreaks under monitoring in 2026 | UKHSA | 0.59 |

#### çŒ´ç—˜ï¼ˆMpoxï¼‰

<p class="key-answer" data-question="çŒ´ç—˜ç–«æƒ…ç¾æ³å¦‚ä½•">UKHSA æŒçºŒæ›´æ–° Mpox clade Ib åŠ clade IIb ç–«æƒ…ç›£æ¸¬ï¼Œ2025 å¹´å…¨çƒç´¯è¨ˆ 98 åœ‹å ±å‘Š 52,000 é¤˜ä¾‹ï¼Œ215 ä¾‹æ­»äº¡ï¼Œæ­æ´²å‡ºç¾ Ib å‹ç¤¾å€å‚³æ’­ã€‚</p>

**è‹±åœ‹æµè¡Œç—…å­¸æ¦‚æ³æ›´æ–°ï¼ˆ2/12ï¼‰**ï¼š
- UKHSA æŒçºŒæ›´æ–° Mpox clade Ib åŠ clade IIb ç–«æƒ…ç›£æ¸¬å ±å‘Š
- è‡ª 2022 å¹´ 6 æœˆèµ·è¿½è¹¤ clade IIb ç—…ä¾‹
- 2025 å¹´ 1 æœˆå¾Œç´å…¥ clade Ib ç›£æ¸¬æ•¸æ“š

**å…¨çƒç–«æƒ…**ï¼š
- 2025 å¹´å…¨çƒç´¯è¨ˆï¼š98 åœ‹å ±å‘Š 52,000 é¤˜ä¾‹ï¼Œ215 ä¾‹æ­»äº¡
- ä¸»è¦ç–«å€ï¼šéæ´²ï¼ˆå‰›æœæ°‘ä¸»å…±å’Œåœ‹ã€å¹¾å…§äºç­‰ï¼Œä»¥ Ib å‹ç‚ºä¸»ï¼‰
- æ­æ´²ç¤¾å€å‚³æ’­ï¼šæ³•åœ‹ã€ç¾©å¤§åˆ©ã€è¥¿ç­ç‰™å‡ºç¾ Ib å‹ç¤¾å€å‚³æ’­

ä¾†æºï¼šuk_ukhsa_updates/surveillance/2026-02-12-mpox-clade-ib-and-iib-outbreak-epidemiological-overview.md

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2026-02-12 | Mpox clade Ib and clade IIb outbreak: epidemiological overview | UKHSA | 0.79 |
| 2025-06-18 | Clade Ib Mpox Outbreak - Kenya, July 2024-February 2025 | US CDC MMWR | 0.74 |
| 2025-01-14 | Epidemiological update: Mpox due to monkeypox virus clade I | ECDC | 0.67 |

#### æµæ„Ÿï¼ˆInfluenzaï¼‰

<p class="key-answer" data-question="æµæ„Ÿç–«æƒ…ç¾æ³å¦‚ä½•">å…¨çƒæµæ„Ÿæ´»å‹•åº¦é«˜ï¼Œä¸»è¦æµè¡Œæ ªç‚º A(H3N2) K åˆ†æ”¯è®Šç•°æ ªï¼›å°ç£æœ¬æµæ„Ÿå­£ç´¯è¨ˆ 529 ä¾‹é‡ç—‡ã€97 ä¾‹æ­»äº¡ï¼Œ60% ç‚º 65 æ­²ä»¥ä¸Šé•·è€…ã€‚</p>

- **å…¨çƒæ´»å‹•åº¦**ï¼šé«˜
- **ä¸»è¦æµè¡Œæ ª**ï¼šA(H3N2) K åˆ†æ”¯è®Šç•°æ ª
- **å°ç£ç–«æƒ…**ï¼š
  - æœ¬æµæ„Ÿå­£ç´¯è¨ˆ 529 ä¾‹é‡ç—‡ã€97 ä¾‹æ­»äº¡
  - é‡ç—‡ç—…ä¾‹ï¼š60% ç‚º 65 æ­²ä»¥ä¸Šé•·è€…ï¼Œ82% å…·æ…¢æ€§ç—…å²
  - å…¬è²»æµæ„Ÿç–«è‹—å‰©é¤˜ç´„ 9.3 è¬åŠ‘

#### ç¦½æµæ„Ÿ A(H5N1)

<p class="key-answer" data-question="ç¦½æµæ„Ÿ H5N1 ç–«æƒ…ç¾æ³å¦‚ä½•">2025 å¹´å…¨çƒå…± 30 ä¾‹äººé¡æ„ŸæŸ“ï¼Œ12 ä¾‹æ­»äº¡ï¼Œä¸»è¦é€šå ±åœ‹å®¶ç‚ºæŸ¬åŸ”å¯¨ï¼ˆ18 ä¾‹ï¼‰ã€ä¸­åœ‹ã€ç¾åœ‹ã€è‹±åœ‹ï¼›å°ç£å°ä¸­åœ‹åŠæŸ¬åŸ”å¯¨ç¶­æŒç¬¬äºŒç´šæ—…éŠè­¦ç¤ºã€‚</p>

- **å…¨çƒç—…ä¾‹æ•¸**ï¼š2025 å¹´å…± 30 ä¾‹äººé¡æ„ŸæŸ“ï¼Œ12 ä¾‹æ­»äº¡
- **ä¸»è¦é€šå ±åœ‹å®¶**ï¼šæŸ¬åŸ”å¯¨ï¼ˆ18 ä¾‹ï¼‰ã€ä¸­åœ‹ã€ç¾åœ‹ã€è‹±åœ‹ã€è¶Šå—ã€å°åº¦
- **å°ç£ç¦½å ´ç–«æƒ…**ï¼š2026 å¹´æˆªè‡³ 1 æœˆ 30 æ—¥å·²ç™¼ç”Ÿ 7 èµ·
- **æ—…éŠè­¦ç¤º**ï¼šä¸­åœ‹ï¼ˆ15 çœå¸‚ï¼‰ã€æŸ¬åŸ”å¯¨ç¶­æŒç¬¬äºŒç´šè­¦ç¤º

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2025-03-13 | Human Cases of Highly Pathogenic Avian Influenza A(H5N1) - California | US CDC MMWR | 0.67 |
| 2025-09-04 | H5N1 Infection in a Child with No Known Exposure - San Francisco | US CDC MMWR | 0.62 |
| 2024-05-30 | Outbreak of H5N1 in U.S. Dairy Cattle - Two Human Cases | US CDC MMWR | 0.58 |

#### ç«‹ç™¾ç—…æ¯’ç—…ï¼ˆNipah Virus Diseaseï¼‰

<p class="key-answer" data-question="ç«‹ç™¾ç—…æ¯’ç–«æƒ…ç¾æ³å¦‚ä½•">å°åº¦è¥¿å­ŸåŠ æ‹‰é‚¦åŠå­ŸåŠ æ‹‰æŒçºŒæœ‰ç–«æƒ…ï¼›ECDC è©•ä¼°å°æ­æ´²äººé¢¨éšªæ¥µä½ï¼›å°ç£é è¨ˆ 3 æœˆä¸­æ­£å¼å°‡ã€Œç«‹ç™¾ç—…æ¯’æ„ŸæŸ“ç—‡ã€åˆ—ç‚ºç¬¬äº”é¡æ³•å®šå‚³æŸ“ç—…ã€‚</p>

- **ç–«æƒ…åœ°é»**ï¼šå°åº¦è¥¿å­ŸåŠ æ‹‰é‚¦ï¼ˆ2026/1/13 ç¢ºèªçˆ†ç™¼ï¼‰ã€å­ŸåŠ æ‹‰ï¼ˆæŒçºŒï¼‰
- **é¢¨éšªè©•ä¼°**ï¼šECDC è©•ä¼°å°æ­æ´²äººé¢¨éšªæ¥µä½ï¼›WHO è©•ä¼°å…¨çƒé¢¨éšªä»å±¬ä½åº¦
- **æ”¿ç­–å‹•æ…‹**ï¼šå°ç£é è¨ˆ 3 æœˆä¸­æ­£å¼å°‡ã€Œç«‹ç™¾ç—…æ¯’æ„ŸæŸ“ç—‡ã€åˆ—ç‚ºç¬¬äº”é¡æ³•å®šå‚³æŸ“ç—…
- **HCID æ¸…å–®**ï¼šUKHSA å·²æ–¼ 2/18 æ›´æ–° HCID åœ‹å®¶é¢¨éšªæ¸…å–®ï¼Œå°‡å°åº¦è¥¿å­ŸåŠ æ‹‰é‚¦ç–«æƒ…ç´å…¥è¿½è¹¤

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2026-01-29 | Nipah virus disease cases reported in West Bengal, India | ECDC | 0.62 |
| 2026-01-29 | Nipah virus: what is it, where is it found and how does it spread? | UKHSA | 0.61 |

### é¢¨éšªè©•ä¼°æ›´æ–°

#### ECDC ç¬¬ 7 é€±å‚³æŸ“ç—…å¨è„…å ±å‘Š

ECDC æ–¼ 2 æœˆ 13 æ—¥ç™¼å¸ƒ 2026 å¹´ç¬¬ 7 é€±ï¼ˆ2/7-2/13ï¼‰å‚³æŸ“ç—…å¨è„…å ±å‘Šï¼š

**ç›£æ¸¬é …ç›®**ï¼š
- å‘¼å¸é“ç—…æ¯’æµè¡Œç—…å­¸ï¼ˆEU/EEAï¼‰
- å¤§å‹é›†æœƒæ´»å‹•ç›£æ¸¬
- ç¦½æµæ„Ÿï¼ˆAvian influenzaï¼‰
- å±ˆå…¬ç—…ï¼ˆChikungunyaï¼‰
- ç™»é©ç†±ï¼ˆDengueï¼‰
- å°¼å¸•ç—…æ¯’ç—…ï¼ˆNipah virus diseaseï¼‰
- éº»ç–¹ï¼ˆMeaslesï¼‰

ä¾†æºï¼šecdc_cdtr/surveillance/2026-02-13-communicable-disease-threats-report-7-13-february-2026-week-7.md

#### ç‹‚çŠ¬ç—…æš´éœ²å‰ç–«è‹—ç”³è«‹è¡¨å–®æ›´æ–° â€” è‹±åœ‹

UKHSA æ–¼ 2 æœˆ 18 æ—¥æ›´æ–°ç‹‚çŠ¬ç—…æš´éœ²å‰ç–«è‹—ç”³è«‹è¡¨å–®ï¼š

- é©ç”¨æ–¼è‹±æ ¼è˜­èˆ‡å¨çˆ¾æ–¯åœ°å€è·æ¥­æš´éœ²é¢¨éšªæ—ç¾¤
- ä¸»è¦å°è±¡ï¼šè™è è™•ç†äººå“¡ã€é‡ç”Ÿå‹•ç‰©å·¥ä½œè€…ã€å¯¦é©—å®¤äººå“¡
- ç”¨é€”ï¼šéæ—…éŠç”¨é€”çš„æš´éœ²å‰é é˜²æ€§æ¥ç¨®ï¼ˆPrEPï¼‰

ä¾†æºï¼šuk_ukhsa_updates/guidance/2026-02-18-rabies-pre-exposure-request-form.md **[æœ¬é€±æ–°å¢]**

---

## å€åŸŸå‹•æ…‹

### æ­æ´² (ECDC)

**ç¬¬ 8 é€±ä¸»è¦å‹•æ…‹ï¼ˆ2026/2/14-2/19ï¼‰**

| å¨è„…é …ç›® | ç‹€æ…‹ |
|----------|------|
| é£Ÿæºæ€§ç´°èŒæŠ—è—¥æ€§ | ECDC/EFSA è¯åˆè­¦å‘Š **[æœ¬é€±æ–°å¢]** |
| RSV ç–«è‹—è¨ˆç•« | è‹±åœ‹ç™¼å¸ƒ PGD ç¯„æœ¬ |
| åœ‹éš›åˆä½œ | PHAC è¨ªå• ECDC |
| å…’ç«¥ç–«è‹—æ¥ç¨® | è‹±åœ‹æ¨å‹•å®£å‚³æ´»å‹• |
| éº»ç–¹ (Measles) | æŒçºŒç›£æ¸¬ |
| å‘¼å¸é“ç—…æ¯’ | EU/EEA æŒçºŒç›£æ¸¬ |

**æœ¬é€±é‡è¦ç™¼å¸ƒ**ï¼š
- **é£Ÿæºæ€§ç´°èŒæŠ—è—¥æ€§è¯åˆå ±å‘Š**ï¼ˆ2/18ï¼‰ï¼šç’°ä¸™æ²™æ˜ŸæŠ—è—¥æ€§é«˜ä¼ï¼Œç¢³é’é»´çƒ¯é…¶ç”¢ç”Ÿå‹å¤§è…¸æ¡¿èŒä¸Šå‡
- **RSV ç–«è‹— PGD ç¯„æœ¬**ï¼ˆ2/17ï¼‰ï¼šæ”¯æ´å­•å©¦åŠé•·è€…ç–«è‹—æ¥ç¨®è¨ˆç•«
- **å…’ç«¥ç–«è‹—æ¥ç¨®å®£å‚³**ï¼ˆ2/16ï¼‰ï¼šæå‡ MMR ç­‰ç–«è‹—æ¥ç¨®ç‡
- **ECDC-PHAC åˆä½œ**ï¼ˆ2/16ï¼‰ï¼šåŠ å¼·åœ‹éš›å…¬è¡›åˆä½œ

### è‹±åœ‹ (UKHSA)

**æœ¬é€±é‡è¦æ›´æ–°**

| é¡å‹ | äº‹ä»¶ | æ—¥æœŸ |
|------|------|------|
| **ç›£æ¸¬å ±å‘Š** | **é¦–ä»½å¯’å†·æ­»äº¡ç‡å ±å‘Š** | **2/18** |
| **æŒ‡å¼•æ›´æ–°** | **HCID åœ‹å®¶é¢¨éšªæ¸…å–®** | **2/18** |
| æŒ‡å¼•æ›´æ–° | ç‹‚çŠ¬ç—…æš´éœ²å‰ç–«è‹—ç”³è«‹è¡¨å–® | 2/18 |
| æŒ‡å¼•æ›´æ–° | å¯’å†·æ­»äº¡ç‡ QMI æ–‡ä»¶ | 2/18 |
| æŒ‡å¼•ç™¼å¸ƒ | RSV ç–«è‹— PGD ç¯„æœ¬ | 2/17 |
| æ”¿ç­–å®£å‚³ | å…’ç«¥ç–«è‹—æ¥ç¨®æ´»å‹• | 2/16 |
| æŒ‡å¼•ç™¼å¸ƒ | MMR ç–«è‹—æ˜“è®€æŒ‡å— | 2/16 |
| æŒ‡å¼•æ›´æ–° | ç”¢å‰ä¸€æ°§åŒ–ç¢³æª¢æŸ¥æ¼”ç®—æ³• | 2/16 |
| æŒ‡å¼•æ›´æ–° | çµæ ¸ç—…è³‡è¨Šæ‰‹å†Š | 2/13 |
| ç›£æ¸¬å ±å‘Š | Mpox clade Ib/IIb æµè¡Œç—…å­¸æ¦‚æ³ | 2/12 |
| ç›£æ¸¬å ±å‘Š | RSV ç–«è‹—æ¥ç¨®è¦†è“‹ç‡ | 2/12 |

**é‡é»è­°é¡Œ**ï¼š
- **å¯’å†·æ­»äº¡ç‡ç›£æ¸¬**ï¼šé¦–ä»½å¹´åº¦å ±å‘Šç™¼å¸ƒï¼Œ2,544 ä¾‹æ­»äº¡èˆ‡å¯’å†·å¤©æ°£ç›¸é—œ
- **HCID é¢¨éšªè©•ä¼°**ï¼šæ›´æ–°å…¨çƒé«˜å¾Œæœå‚³æŸ“ç—…åœ‹å®¶é¢¨éšªæ¸…å–®
- **ç–«è‹—è¨ˆç•«é€²å±•**ï¼šRSVã€MMRVã€å…’ç«¥å¸¸è¦ç–«è‹—æŒçºŒæ¨å‹•

### äºå¤ªåœ°å€

**å°ç£ (tw_cdc_alerts)**

| äº‹ä»¶ | ç›£æ¸¬æˆªæ­¢ | ç‹€æ…‹ |
|------|----------|------|
| é¦–ä¾‹éº»ç–¹å¢ƒå¤–ç§»å…¥ | 2/28 | 400 åæ¥è§¸è€…ç›£æ¸¬ä¸­ |
| é¦–ä¾‹ç™¾æ—¥å’³ç¢ºè¨º | 3/4 | å®¶åº­æ¥è§¸è€…ç›£æ¸¬ä¸­ |
| æµæ„Ÿç–«æƒ… | æŒçºŒ | é«˜å³°æœŸï¼Œå…¬è²»ç–«è‹—å‰©ç´„ 9.3 è¬åŠ‘ |

**æ˜¥ç¯€é€£å‡å¾Œæé†’**ï¼š
- è¾²æ›†æ˜¥ç¯€ï¼ˆ2/17-2/19ï¼‰æœŸé–“ 163 å®¶é†«é™¢é…åˆé–‹è¨­å‚³æŸ“ç—…ç‰¹åˆ¥é–€è¨º
- è¿”åœ‹å¾Œ 3 é€±å…§å‡ºç¾ç™¼ç‡’ã€å‘¼å¸é“ç—‡ç‹€æ‡‰å„˜é€Ÿå°±é†«

**å°åº¦**ï¼š
- è¥¿å­ŸåŠ æ‹‰é‚¦ç«‹ç™¾ç—…æ¯’ç–«æƒ…æŒçºŒç›£æ¸¬ä¸­ï¼ˆ2026/1/13 ç¢ºèªçˆ†ç™¼ï¼‰

**æ—¥æœ¬**ï¼š
- ç™¾æ—¥å’³ç–«æƒ…åš´å³»ï¼š2025 å¹´å…¨å¹´é€¾ 8 è¬ä¾‹ï¼ˆæ­·å¹´æœ€é«˜ï¼‰

### ç¾æ´²

**æ—…éŠå¥åº·é€šçŸ¥**ï¼š
- **Level 2ï¼ˆç¶­æŒï¼‰**ï¼šè˜‡åˆ©å—ã€å¡å¸­çˆ¾ â€” å±ˆå…¬ç—…
- **Level 2ï¼ˆç¶­æŒï¼‰**ï¼šè¿¦ç´ã€è³´æ¯”ç‘äº â€” Clade II çŒ´ç—˜
- **Level 1ï¼ˆç¶­æŒï¼‰**ï¼šå…¨çƒç™»é©ç†±é¢¨éšª

**éº»ç–¹ç–«æƒ…**ï¼šç¾åœ‹ã€åŠ æ‹¿å¤§ã€å¢¨è¥¿å“¥è¿‘æœŸæŒçºŒæœ‰ç—…ä¾‹ç™¼ç”Ÿ

---

## æ—…éŠå¥åº·å»ºè­°

### è¾²æ›†æ˜¥ç¯€å¾Œè¿”åœ‹æé†’

<p class="key-answer" data-question="æ˜¥ç¯€å‡ºåœ‹æ—…éŠå¾Œè¿”åœ‹æ‡‰æ³¨æ„ä»€éº¼">æ˜¥ç¯€å‡ºåœ‹æ—…éŠè¿”åœ‹å¾Œ 3 é€±å…§ï¼Œè‹¥å‡ºç¾ç™¼ç‡’ã€å‘¼å¸é“ç—‡ç‹€ã€è…¹ç€‰æˆ–çš®ç–¹ç­‰ï¼Œæ‡‰å„˜é€Ÿå°±é†«ä¸¦ä¸»å‹•å‘ŠçŸ¥æ—…éŠå²ã€‚</p>

<ol class="actionable-steps">
<li>è¿”åœ‹å¾Œ 3 é€±å…§å‡ºç¾ç™¼ç‡’ã€ç´…ç–¹ã€å’³å—½ç­‰ç—‡ç‹€æ‡‰å„˜é€Ÿå°±é†«</li>
<li>ä¸»å‹•å‘ŠçŸ¥é†«å¸«æ—…éŠå²åŠæš´éœ²å²</li>
<li>å‡ºç¾è…¹ç€‰ç—‡ç‹€æ‡‰åœ¨å®¶ä¼‘æ¯è‡³ç—‡ç‹€è§£é™¤è‡³å°‘ 48 å°æ™‚</li>
<li>æœ‰å‘¼å¸é“ç—‡ç‹€æ™‚æ‡‰æˆ´å£ç½©ä¸¦è½å¯¦æ‰‹éƒ¨è¡›ç”Ÿ</li>
</ol>

### Level 2 - åŠ å¼·é˜²è­·æªæ–½

| ç›®çš„åœ° | ç–¾ç—… | å»ºè­° |
|--------|------|------|
| è˜‡åˆ©å—ã€å¡å¸­çˆ¾ | å±ˆå…¬ç—… (Chikungunya) | é˜²èšŠæªæ–½ |
| è¿¦ç´ã€è³´æ¯”ç‘äº | çŒ´ç—˜ (Clade II) | é¿å…æ¥è§¸ç—…æ‚£ã€é‡ç”Ÿå‹•ç‰© |
| ä¸­åœ‹ï¼ˆ15çœå¸‚ï¼‰ã€æŸ¬åŸ”å¯¨ | ç¦½æµæ„Ÿ H5N1 | é¿å…æ¥è§¸ç¦½é³¥ |
| è¶Šå—ã€å°å°¼ã€å°åº¦ç­‰ 7 åœ‹ | éº»ç–¹ | ç¢ºèª MMR ç–«è‹—æ¥ç¨®ç‹€æ…‹ |

### Level 1 - ä¸€èˆ¬é˜²è­·æªæ–½

| ç›®çš„åœ° | ç–¾ç—… | å»ºè­° |
|--------|------|------|
| å…¨çƒå¤šåœ‹ | ç™»é©ç†± | é˜²èšŠæªæ–½ |
| å…¨çƒå¤šåœ‹ | éº»ç–¹ | ç¢ºèª MMR ç–«è‹—æ¥ç¨®ç‹€æ…‹ |

### ç«‹ç™¾ç—…æ¯’æµè¡Œå€æ³¨æ„äº‹é …

**å°åº¦è¥¿å­ŸåŠ æ‹‰é‚¦ã€å–€æ‹‰æ‹‰é‚¦ï¼›å­ŸåŠ æ‹‰**ï¼š
- é¿å…æ¥è§¸è™è æˆ–è±¬éš»
- é¿å…é£²ç”¨ç”Ÿæ¤°æ£—æ¨¹æ±åŠé£Ÿç”¨å¯èƒ½è¢«æ±¡æŸ“çš„æ°´æœ
- ä¿æŒè‰¯å¥½æ‰‹éƒ¨è¡›ç”Ÿ

### é«˜å¾Œæœå‚³æŸ“ç—… (HCID) æ—…éŠæ³¨æ„äº‹é …

å‰å¾€ HCID é¢¨éšªåœ‹å®¶çš„æ—…å®¢æ‡‰ï¼š
- æŸ¥é–± UKHSA æœ€æ–°åœ‹å®¶é¢¨éšªæ¸…å–®
- äº†è§£ç›®çš„åœ°çš„ HCID é¢¨éšªé¡å‹
- æº–å‚™é©ç•¶çš„å€‹äººé˜²è­·æªæ–½
- è¿”åœ‹å¾Œå¦‚æœ‰ç™¼ç‡’ç­‰ç—‡ç‹€ï¼Œä¸»å‹•å‘ŠçŸ¥é†«ç™‚äººå“¡æ—…éŠå²

---

## å…¬å…±è¡›ç”ŸæŒ‡å¼•

### å¯’å†·å¤©æ°£å¥åº·é˜²è­·ï¼ˆæ–°å¢ï¼‰

<p class="key-answer" data-question="å¦‚ä½•åœ¨å¯’å†·å¤©æ°£ä¸­ä¿è­·å¥åº·">å¯’å†·å¤©æ°£é˜²è­·é‡é»åŒ…æ‹¬ï¼šä¿æŒå®¤å…§æº«æš–ï¼ˆè‡³å°‘ 18Â°Cï¼‰ã€å¤šå±¤ç©¿è‘—ã€æ³¨æ„å¿ƒè¡€ç®¡ç—‡ç‹€ã€ç¢ºä¿å……è¶³æš–æ°£å’Œé£Ÿç‰©ä¾›æ‡‰ï¼Œç‰¹åˆ¥æ˜¯ 65 æ­²ä»¥ä¸Šé•·è€…åŠæ…¢æ€§ç—…æ‚£è€…ã€‚</p>

**é«˜é¢¨éšªæ—ç¾¤**ï¼š
<ol class="actionable-steps">
<li>65 æ­²ä»¥ä¸Šé•·è€…ï¼šç¢ºä¿å®¤å…§æº«åº¦è‡³å°‘ 18Â°C</li>
<li>å¿ƒè¡€ç®¡ç–¾ç—…æ‚£è€…ï¼šæ³¨æ„èƒ¸æ‚¶ã€å‘¼å¸å›°é›£ç­‰ç—‡ç‹€</li>
<li>å‘¼å¸ç³»çµ±ç–¾ç—…æ‚£è€…ï¼šæ¸›å°‘å¤–å‡ºï¼Œé¿å…å†·ç©ºæ°£åˆºæ¿€</li>
<li>å¤±æ™ºç—‡æ‚£è€…ï¼šç”±ç…§è­·è€…ç¢ºä¿ä¿æš–æªæ–½</li>
</ol>

### RSV ç–«è‹—æ¥ç¨®ï¼ˆè‹±åœ‹æ–°æŒ‡å¼•ï¼‰

<p class="key-answer" data-question="RSV ç–«è‹—çš„é©ç”¨å°è±¡">è‹±åœ‹ RSV ç–«è‹—è¨ˆç•«é‡å°å­•å©¦ï¼ˆä¿è­·å¬°å…’ï¼‰ã€75 æ­²ä»¥ä¸Šé•·è€…åŠè€å¹´è­·ç†æ©Ÿæ§‹ä½æ°‘ã€‚</p>

**ç›®æ¨™æ—ç¾¤**ï¼š
<ol class="actionable-steps">
<li>å­•å©¦ï¼šé€éæ¥ç¨®å°‡æŠ—é«”å‚³éçµ¦æ–°ç”Ÿå¬°å…’</li>
<li>75 æ­²ä»¥ä¸Šé•·è€…ï¼šç›´æ¥ä¿è­·</li>
<li>è€å¹´è­·ç†æ©Ÿæ§‹ä½æ°‘ï¼šç›´æ¥ä¿è­·</li>
</ol>

### MMR ç–«è‹—æ¥ç¨®

**é©ç”¨å°è±¡**ï¼š
- 12 å€‹æœˆå¤§ï¼šç¬¬ä¸€åŠ‘
- 18 å€‹æœˆå¤§ï¼šç¬¬äºŒåŠ‘
- 6 å€‹æœˆä»¥ä¸Šæœªæ»¿ 1 æ­²å¬°å…’å‰å¾€æµè¡Œå€ï¼Œå¯å‡ºç™¼å‰ 2-4 é€±è‡ªè²»æ¥ç¨®

### ç™¾æ—¥å’³é é˜²

<ol class="actionable-steps">
<li><strong>å¬°å¹¼å…’å¸¸è¦æ¥ç¨®</strong>ï¼šå‡ºç”Ÿæ»¿ 2ã€4ã€6ã€18 å€‹æœˆåŠæ»¿ 5 æ­²è‡³å…¥å­¸å‰å„æ¥ç¨®ä¸€åŠ‘</li>
<li><strong>å­•å©¦æ¥ç¨®ï¼ˆé‡è¦ï¼‰</strong>ï¼šå»ºè­°æ¯æ¬¡æ‡·å­•è‡ªè²»æ¥ç¨® 1 åŠ‘ Tdap ç–«è‹—ï¼Œä»¥æ‡·å­•ç¬¬ 27-36 é€±æ¥ç¨®æ•ˆç›Šæœ€å¤§åŒ–</li>
<li><strong>ç…§é¡§è€…æ¥ç¨®</strong>ï¼šå»ºè­°å¬°å…’ç…§é¡§è€…è‡ªè²»æ¥ç¨®ä¸€åŠ‘ Tdap ç–«è‹—</li>
</ol>

### æŠ—ç”Ÿç´ æŠ—è—¥æ€§é˜²è­·å»ºè­°

<p class="key-answer" data-question="å¦‚ä½•æ¸›å°‘æŠ—ç”Ÿç´ æŠ—è—¥æ€§é¢¨éšª">æ¸›å°‘æŠ—ç”Ÿç´ æŠ—è—¥æ€§çš„é—œéµåŒ…æ‹¬ï¼šåƒ…åœ¨é†«å¸«è™•æ–¹æ™‚ä½¿ç”¨æŠ—ç”Ÿç´ ã€å®Œæˆæ•´å€‹ç™‚ç¨‹ã€æ³¨æ„é£Ÿå“è¡›ç”Ÿã€æ­£ç¢ºè™•ç†ç”Ÿè‚‰ã€‚</p>

<ol class="actionable-steps">
<li>åƒ…åœ¨é†«å¸«è™•æ–¹æ™‚ä½¿ç”¨æŠ—ç”Ÿç´ ï¼Œä¸è‡ªè¡Œè³¼è²·æˆ–åˆ†äº«</li>
<li>å³ä½¿ç—‡ç‹€æ”¹å–„ä¹Ÿè¦å®Œæˆæ•´å€‹æŠ—ç”Ÿç´ ç™‚ç¨‹</li>
<li>è™•ç†ç”Ÿè‚‰æ™‚æ³¨æ„é£Ÿå“è¡›ç”Ÿï¼Œé¿å…äº¤å‰æ±¡æŸ“</li>
<li>è‚‰é¡æ‡‰å¾¹åº•ç…®ç†Ÿ</li>
</ol>

---

## è³‡æ–™ä¾†æº

æœ¬å ±å‘ŠåŸºæ–¼ä»¥ä¸‹ä¾†æºï¼š
- ECDC å‚³æŸ“ç—…å¨è„…å ±å‘Š (ecdc_cdtr)
- WHO ç–¾ç—…ç–«æƒ…æ–°è (who_disease_outbreak_news)
- US CDC å¥åº·è­¦å ±ç¶²çµ¡ (us_cdc_han)
- US CDC MMWR é€±å ± (us_cdc_mmwr)
- US CDC æ—…éŠå¥åº·é€šçŸ¥ (us_travel_health_notices)
- å°ç£ç–¾ç®¡ç½²å…¬å‘Š (tw_cdc_alerts)
- UK Health Security Agency (uk_ukhsa_updates)

### æœ¬é€±å¼•ç”¨è³‡æ–™

**ECDC (ecdc_cdtr)**
- `guidance/2026-02-18-antimicrobial-resistance-foodborne-bacteria.md` **[æœ¬é€±æ–°å¢]**
- `situational_update/2026-02-16-phac-visits-ecdc-collaboration.md`
- `surveillance/2026-02-13-communicable-disease-threats-report-7-13-february-2026-week-7.md`

**UK UKHSA (uk_ukhsa_updates)**
- `surveillance/2026-02-18-ukhsa-publishes-first-cold-mortality-report.md` **[æœ¬é€±æ–°å¢]**
- `surveillance/2026-02-18-cold-weather-health-impact-report.md` **[æœ¬é€±æ–°å¢]**
- `surveillance/2026-02-18-cold-mortality-monitoring-report-england-winter-2024-to-2025.md` **[æœ¬é€±æ–°å¢]**
- `guidance/2026-02-18-high-consequence-infectious-disease-country-specific-risk.md` **[æœ¬é€±æ–°å¢]**
- `guidance/2026-02-18-cold-mortality-monitoring-report-england-quality-and-methodology-information.md` **[æœ¬é€±æ–°å¢]**
- `guidance/2026-02-18-pre-release-access-lists-cold-mortality-monitoring-reports.md` **[æœ¬é€±æ–°å¢]**
- `guidance/2026-02-18-rabies-pre-exposure-request-form.md` **[æœ¬é€±æ–°å¢]**
- `guidance/2026-02-17-respiratory-syncytial-virus-rsv-vaccine-pgd-template.md`
- `policy/2026-02-16-parents-vaccination-campaign.md`
- `guidance/2026-02-16-easy-read-guide-mmr-vaccination.md`
- `guidance/2026-02-16-carbon-monoxide-antenatal-checks-algorithm.md`
- `guidance/2026-02-13-tuberculosis-tb-factsheet.md`
- `surveillance/2026-02-12-mpox-clade-ib-and-iib-outbreak-epidemiological-overview.md`
- `surveillance/2026-02-12-rsv-maternal-vaccination-coverage-in-england.md`
- `surveillance/2026-02-12-rsv-older-adults-vaccination-coverage-in-england-statistics.md`
- `guidance/2026-02-12-brucella-laboratory-and-clinical-services.md`
- `surveillance/2026-02-10-pneumococcal-disease-non-pcv13-serotypes.md`
- `guidance/2026-02-10-mmrv-programme-healthcare-practitioners.md`

**å°ç£ç–¾ç®¡ç½² (tw_cdc_alerts)**
- `policy/2026-02-13-spring-festival-epidemic-prevention.md`
- `imported_case/2026-02-12-measles-imported-case-vietnam.md`
- `domestic_outbreak/2026-02-12-pertussis-first-case.md`
- `policy/2026-02-10-cold-wave-lunar-new-year-flu-covid-policy.md`
- `medical_advisory/2026-02-10-lunar-new-year-hiv-mpox-prevention.md`
- `disease_info/2026-02-10-rabies-prevention-outdoor-activities.md`

**US CDC (us_travel_health_notices)**
- `level_2_practice/2026-02-05-chikungunya-suriname.md`
- `level_2_practice/2026-02-05-chikungunya-seychelles.md`
- `level_2_practice/2026-01-26-monkeypox-ghana-liberia.md`
- `level_1_watch/2026-01-22-dengue-global.md`

### èªæ„æœå°‹æŸ¥è©¢ç´€éŒ„

æœ¬å ±å‘Šä½¿ç”¨ Qdrant èªæ„æœå°‹æä¾›æ­·å²è„ˆçµ¡ï¼ŒåŸ·è¡Œä»¥ä¸‹æŸ¥è©¢ï¼š

| æŸ¥è©¢ | æ‰¾åˆ°ç­†æ•¸ | æœ€é«˜ç›¸é—œåˆ†æ•¸ |
|------|----------|--------------|
| antimicrobial resistance foodborne bacteria Salmonella | 5 | 0.65 |
| cold weather mortality winter health England | 5 | 0.72 |
| RSV respiratory syncytial virus vaccine | 8 | 0.72 |
| measles outbreak vaccination 2026 | 8 | 0.65 |
| pertussis whooping cough outbreak 2025 2026 | 8 | 0.64 |
| mpox clade Ib outbreak 2025 2026 | 8 | 0.79 |
| avian influenza H5N1 2025 2026 | 8 | 0.67 |
| nipah virus India outbreak 2026 | 8 | 0.62 |

---

## åˆ†äº«æœ¬é€±å ±

<div class="share-buttons">

[åˆ†äº«è‡³ Facebook](https://www.facebook.com/sharer/sharer.php?u=https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W08-weekly-digest){: .btn .btn-outline target="_blank" rel="noopener" }
[åˆ†äº«è‡³ Twitter](https://twitter.com/intent/tweet?url=https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W08-weekly-digest&text=EpiAlert%20ç–«æƒ…å¿«è¨Š%202026-W08%20é€±å ±){: .btn .btn-outline target="_blank" rel="noopener" }
[åˆ†äº«è‡³ LINE](https://social-plugins.line.me/lineit/share?url=https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W08-weekly-digest){: .btn .btn-outline target="_blank" rel="noopener" }

</div>

---

## å¼•ç”¨æœ¬é€±å ±

<div class="citation-block" style="background: #f6f8fa; border-left: 4px solid #0366d6; padding: 1rem; margin: 1rem 0;">

**APA æ ¼å¼**

<code style="display: block; background: white; padding: 0.5rem; margin-top: 0.5rem; font-size: 0.9rem; word-break: break-all;">
EpiAlert AI ç·¨è¼¯. (2026, February 18). å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W08. EpiAlert ç–«æƒ…å¿«è¨Š. https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W08-weekly-digest
</code>

**BibTeX æ ¼å¼**

<pre style="background: white; padding: 0.5rem; margin-top: 0.5rem; font-size: 0.85rem; overflow-x: auto;">
@misc{epialert2026w08,
  author = {{EpiAlert AI ç·¨è¼¯}},
  title = {å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W08},
  year = {2026},
  month = {February},
  day = {18},
  howpublished = {EpiAlert ç–«æƒ…å¿«è¨Š},
  url = {https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W08-weekly-digest},
  note = {Accessed: 2026-02-20}
}
</pre>

</div>

<button onclick="window.print()" class="btn btn-outline" style="margin-top: 0.5rem;">
  ğŸ–¨ï¸ åˆ—å° / åŒ¯å‡º PDF
</button>

<style>
@media print {
  .site-nav, .site-footer, .share-buttons, .citation-block, button, #region-filter { display: none !important; }
  .main-content { max-width: 100% !important; }
}
</style>

---

*å ±å‘Šç”¢å‡ºæ™‚é–“: 2026-02-19T14:00:00+08:00*
*ä¸‹æ¬¡æ›´æ–°: 2026-02-25 (2026-W09 é€±å ±)*
